drugset / Trial / NCT06264414
Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of the DTT106 in the treatment of erectile dysfunction associated with benign prostatic hyperplasia
Timeline
- Start
- 2025-02
- Primary completion
- 2026-06
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DTT106 | Unknown | — | Oral |
| Comparator | Dutasteride | Small molecule | 0.5 mg | Oral |
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | Oral |